We're sunsetting PodQuest on 2025-07-28. Thank you for your support!
Export Podcast Subscriptions
cover of episode Bad Magic | The Data are the Data | S4-E5

Bad Magic | The Data are the Data | S4-E5

2024/2/12
logo of podcast Dr. Death

Dr. Death

AI Deep Dive AI Chapters Transcript
#biotechnology and neuroscience#legal insights#political scandals#social issues#villain analysis#medical practice#financial influencer insights#revenge narrative#serial killer investigation#journalism and writing insights People
B
Brooke Casey
G
Guy Roken
J
Jeffrey Drew
M
Mark Dybul (Enochian CEO)
N
Nate (Hindenburg)
R
Rene Sendlove
T
Thomas (Hindenburg)
U
Ule Abelgo
Z
Zebariah Newman
Topics
@Jeffrey Drew : 我参与的HIV试验似乎有效,但我想知道注射是否真的能让我产生免疫力。如果试验成功,Serhat会赚很多钱,但我什么也得不到。我为可能帮助他人而感到自豪,但这一切都被夺走了,我不得不重新开始服药,这让我感到非常沮丧。 @Zebariah Newman : Serhat医生可能遇到麻烦了。我最关心的是杰弗里的状况,我开始怀疑杰弗里的“无法检测到”的状态是否真实。在杰弗里的故事被完全遗忘了,他为纪念因艾滋病去世的兄弟们所做的牺牲也被遗忘了。 @Ule Abelgo : 我对Serhat被指控雇凶杀人感到震惊和难以置信。我很难理解一个人怎么能同时冒充医生、参与雇凶杀人,又自诩为天才。 Thomas (Hindenburg): 我们有义务在发布报道前,给Enochian的高管们一个解释的机会。如果Enochian的股价继续上涨,这对Hindenburg来说将是经济上的灾难。我质问Rene,作为一家美国上市公司的董事长,怎么能对公司的创始人兼科学创始人是否犯有谋杀罪漠不关心。 Nate (Hindenburg): 我们的文章主要关注Serhat的背景,揭露他伪造学历,没有医学背景,实际上是一个土耳其街头魔术师,因欺诈当地人而逃离该国。我们的做空策略成功了,这次我们赚的钱超过了研究成本。我认为他们会不断地重复这个过程,直到他们真正被阻止。 @Rene Sendlove : 我们知道Serhat在2017年因欺诈和盗窃被捕,但他只支付了400美元的罚款,我认为没有必要讨论这件事。无论发生什么,我仍然认为Serhat是个天才,不管他是不是医生。 Mark Dybul (Enochian CEO): 我们坚持Serhat的资历,但他并没有参与公司的日常运营。科学就是科学,数据就是数据。我们放弃了将HIV治疗进行临床试验的计划。 @Guy Roken : 我对Hindenburg的文章感到震惊,Serhat的行为令人费解。 @Brooke Casey : Serhat正在利用他在狱中的时间来提高他所遇到的人的意识,教授冥想和瑜伽。

Deep Dive

Chapters
The episode begins with Jeffrey Drew's experience in Serhat's HIV trial. Despite initial positive results, Jeffrey grows impatient and frustrated, questioning the trial's outcome and Serhat's motives. The chapter culminates with Jeffrey's suspicion that Serhat might be in trouble.
  • Jeffrey Drew's participation in Serhat's experimental HIV treatment.
  • Jeffrey's impatience and concerns about the lack of transparency.
  • Zebariah Newman's filming of Jeffrey's experience.
  • Jeffrey's suspicion that Serhat is in trouble.

Shownotes Transcript

Translations:
中文

A year before Serhat was arrested, the filmmaker Zebariah Newman climbed out of his car in the parking garage of Serhat's clinic. This was as close as Zeb and his camera were allowed to come to the building itself. In the dim light, he spotted his friend Jeffrey Drew waiting for him. Jeffrey was about to undergo yet another blood draw at Serhat's clinic.

It had been almost two years since Jeffrey started his HIV trial. He'd been getting his blood drawn regularly, and each time he was told that his HIV levels were undetectable. The experimental treatment seemed to be working, but Jeffrey was starting to get impatient. He wanted to know if Serhat's donor cell injections had retrained his immune system to fight the virus.

As Zeb turned on his camera that morning in the parking garage, Jeffrey was having trouble summoning his usual charisma. He's, you know, he's annoyed. He's lacking patience. He even says that morning on film, like, I'm feeling bratty. I don't want to be here or do this anymore. Eventually, Jeffrey got up and trudged inside, alone. When he came back out, his mood wasn't any better. The two men sat in Jeffrey's car, talking.

Jeffrey doesn't cry. He's not a very emotional person, but he was very emotional and he got angry, you know, and he felt a little used and abused. If it was a cure, then Serhat stood to make a lot of money. He said, I think that they might make a billion dollars and I didn't get anything. He said, I didn't even get a fruit basket.

But Jeffrey kept going on with the trial. He'd been risking his life now for nearly two years. It was too late to stop now. Even if someone else made billions from it, he was still hopeful his contribution could make a difference in the fight against HIV/AIDS. Then one day, Zeb heard from Jeffrey. He'd gotten some good news.

There was this idea that Jeffrey was going to go to Washington, D.C. and sit with Dr. Fauci and have a conversation about HIV. And he's going to sit before some organization. They're going to look at his data and they're going to either grant us the money to do a nationwide government funded trial or not. But there was something even more exciting in the works. And they're either going to say Jeffrey is HIV cured or not.

Jeffrey waited to hear more about the trip. He kept reaching out to the clinic, but they kept putting him off. Eventually, in the spring of 2022, Zeb heard from Jeffrey. Oh, I think Dr. Serhat's in trouble. That was a serious understatement. And Jeffrey would soon have a lot more than a trip to worry about. Like, was anything he thought he knew about the doctor actually real?

We're pleased to have ADT as our presenting sponsor. ADT is the brand that millions of Americans trust to help them protect what matters most because of their years of experience, reliability, and safety innovations. And now, when the most trusted name in home security adds the intelligence of Google, you've got a home with no worries. Google is a trademark of Google LLC.

Go to ADT.com today or call 1-800-ADT-ASAP to learn more. From Wondery, I'm Laura Beal, and this is Dr. Death. Bad magic. This is Episode 5, The Data Are the Data. Over 5,000 miles away from Los Angeles, Enochian investor Ule Abelgo sat in his home in Denmark, staring at an email he'd just received.

His mouth hung open in shock. On his screen was an article saying that the company co-founder had been arrested on murder-for-hire charges. As he told the Danish podcast Dr. No, I walked out to the bathroom and threw up. At first, I didn't believe it. Abelgo was used to the boom-and-bust rollercoaster of investing, and he'd stared down major losses in the past without even blinking.

But this arrest was different. This time, someone had been killed, and the motive prosecutors were pursuing connected right back to the biotech company. He found the many sides of the company's scientific founder hard to square. As he told the podcast, It is difficult for me to understand that you can call yourself a doctor without being one. You can be arrested for participating in and hiring assassins,

and at the same time be a genius. Abelgo turned off his phone and locked himself in his bedroom. He knew many people would be calling him with questions, and he wouldn't be able to answer any of them. What's at stake for Minokin at this point is its absolute survival. The Hindenburg team was scrambling to finalize their story after news of Serhat's arrest.

The market was watching Enochian, but that could change any day, so they needed to get their report out as quickly as possible. They worked around the clock checking and rechecking every claim in their article, making sure that every accusation was backed up with evidence. Anything short of that meant... All you have to show for your 12-month investigation is an investment loss on top of all the research expenses, on top of the legal bills...

And in a case like Enochian, you might also have an incredibly wealthy murderous psychopath who's not very fond of you. It wasn't enough for the report to be true. It had to be ironclad.

Thomas, from Hindenburg, knew he needed to put the team's findings to Enochian's executives before the story published. You have the privilege of putting in a final phone call that you've got them bang to rights. Hey, your top scientist has been arrested on murder-for-hire charges. What have you got to say? I mean, that is a real, real buzz.

But this time, things weren't quite that cinematic. That feat of trying to get anybody on the company on the record was an absolute nightmare. The CEO, Mark Dybul, wouldn't take Thomas' calls. Neither would a key member of the board of directors, Carol Brosgard, or the man who brought Serhat into the company, Chairman Rene Sendlove. They were stonewalling, and the strategy was working.

Because each day that Thomas failed to get someone to comment, Enochian's stock was climbing back up. By May 27th, two days after Serhat's arrest, the stock had almost erased its losses. And if it kept climbing, it could be financially disastrous for Hindenburg. We're sorry, your call cannot be completed as dialed.

Two days before Hindenburg planned to go to press, Thomas was still trying to find someone to talk to at Enochian. I just kept trawling and trawling through SEC filings and other documents and finally came across a US phone number, probably several years old. But hey, I think it was a Florida number from recollection. And so I think, well, what the hell? Put in the call.

Guy answers the phone. Hey, is this Rene? Yeah, yeah, it's Rene. It was the Rene Sendlove, the chair of Enochian, the man who had merged his company with Serhat's. Thomas said he was a journalist and Rene stayed on the line. I said, did you know at the time that you did this merger deal, at the time that you announced it, that you were dealing with a felon?

In 2017, Serhat had been arrested on 14 felony counts relating to fraud and theft. It had never been clear how much Rene Andonokian knew about Serhat's criminal charges. Rene's response caught Thomas off guard. And he said, yes, we knew. But he only had to pay a fine of 400 bucks. And I knew exactly what that was about. And I didn't see that there was any need to discuss that.

He also said that he didn't think Serhat had been convicted. Thomas didn't think that was the whole picture. If anyone looked at the case file, they'd see a series of high-value financial thefts and frauds that might concern any potential business partner. So he tried again. Why didn't you stop it? You know, Rene Sindler said to me, he says...

Regardless of anything that's happened, I still have to admit he's a genius, whether he's a doctor or not. Renee's belief in Sarah Hutt's abilities had not changed. It's like, how do you square that circle?

You know, just how do you do it? You hired him because you thought he was a doctor. Everything pointed to the fact that he's a doctor. He can't be a genius whether he's a doctor or not. He's either a genius and a doctor or he's an absolute con man that you've fallen for. But Sindler seemed to believe that both things were possible. Thomas pressed Rene about Serhat's arrest in the murder-for-hire plot. He said, I don't care whether he's guilty or not.

If he is guilty, he needs to be punished for it. And if he's not guilty, well, good for him. How as chairman of a U.S. listed company can you be telling me that you do not care if your founder and scientific founder is guilty or not of conspiracy to murder? We reached out to Rene Sendler for this story, but he declined to comment.

It was June 1st, 2022, a week since Serhat was arrested. The markets were going to open in just over an hour, and Enochian stock was down just 60 cents from where it was before. Nate sat in his office chair reading the story one last time.

We focused largely on his background. So we focused on how he had apparently fabricated every bit of his educational background that we could find, that he didn't graduate with multiple PhDs, that he didn't have any medical background.

degrees or license. He was, in fact, a low-level Turkish street magician who had fled the country after charges of defrauding locals in Turkey. And we also highlighted, of course, his massive white-collar crime spree that he undertook right when he got to the U.S., just really a buffet of various different flavors of white-collar fraud.

The article also detailed his treatment of cancer patients from Denmark and Pennsylvania. We really focused on his history to date to show that this is not the Michelangelo you think you have. This guy is a complete con artist. Nate checked in with his team, and when everyone gave the all clear, he pressed the button to publish their investigation into Serhat Gemurkcu.

and just went outside and took a long walk and smoked a cigarette. And the reaction when I came back was pretty much instantaneous. We get support from ZipRecruiter. Our friends at ZipRecruiter conducted a recent survey and found that the top hiring challenge employers face for 2024 is a lack of qualified candidates. But if you're an employer and need to hire, here's good news. ZipRecruiter has smart tools and features that help you find more qualified candidates fast.

And right now you can try it for free at ZipRecruiter.com slash doctor. So as soon as you post your job, ZipRecruiter's powerful matching technology will show you candidates whose skills and experience match it.

And ZipRecruiter only gets better as you use it. It learns from your preferences as you use their rating tool to rate your candidates. ZipRecruiter will send you more matches from new profiles as they're created on the site. Let ZipRecruiter help you conquer the biggest hiring challenge, finding qualified candidates. See why four out of five employers who post on ZipRecruiter get a quality candidate within the first day.

Just go to this exclusive web address right now to try ZipRecruiter for free. ZipRecruiter.com slash doctor. Again, that's ZipRecruiter.com slash D-O-C-T-O-R. ZipRecruiter, the smartest way to hire. Thanks to ADT, our presenting sponsor. What makes you feel safe? Maybe it's the embrace of a loved one or connecting with an online community. Well, what about knowing that your home is protected by the most trusted name in home security?

Over 6 million Americans trust ADT to help them protect what matters. As a leader of the home security category, ADT has nearly 150 years of experience, reliability, and safety innovations. ADT utilizes the latest technology for customizable and automated home security.

Choose what works for your home with features like motion sensors to Google Nest Cams with no long-term contracts for self-setup systems. Nest Cams and doorbells can tell the difference between a person, package, vehicle, and animal and will alert you when there's activity.

Easily install your smart home DIY security system at your convenience or leave it up to the ADT pros. Either way, ADT makes protecting your home simple. When the most trusted name in home security adds the intelligence of Google, you've got a home with no worries. Go to ADT.com today or call 1-800-ADT-ASAP. Google Nest Cam and Nest Doorbell are trademarks of Google LLC.

ADT, brilliantly safe. Dr. Death is sponsored by BetterHelp. When thinking about relationships, you might assume that the right one should feel effortless. While that's true to some degree, the best relationships are usually those where both people put in the work to make them great.

And that's true whether it's your relationship with friends, work, your significant other, or anyone else. Therapy can be a place to help you identify challenges you face in your relationships so that you can take steps to work past it. I found that therapy is helpful even if you're not actively facing challenges in your relationships. Talking through what's working can positively reinforce healthy habits and boundaries so that when the time comes, you already have the tools to address them.

So if you're thinking about giving therapy a try, BetterHelp is a great place to start. It's entirely online, so it's designed to be convenient, flexible, and suited to your schedule. All you have to do is fill out a brief questionnaire to get matched with a licensed therapist, and you can switch therapists at any time for no additional charge.

Become your own soulmate, whether you're looking for one or not. Visit betterhelp.com slash doctor today to get 10% off your first month. That's betterhelp, H-E-L-P dot com slash doctor. The article began to rocket around the internet. It made its way to Guy Roken, the podcaster who'd interviewed Serhat. I get a DM, a LinkedIn message from someone who I don't know being like, hey, I'm

Have you seen this article? Your podcast episode is referenced. I open it up and the title is Miracle Cures and Murder for Hire. How a spoon bending Turkish magician built a 600 million dollar NASDAQ listed scam based on a lifetime of lies. And boy was I, I was just blown away by this article. He thought back to Serhat's party he'd gone to in the Hollywood Hills.

Suddenly, all the magicians that were there made more sense, but nothing else did. The hiring of the hitman is some next level shit for me. That is, and then, and then those, like the medical fraudulence and the degree of just, I mean, it, it, it's, it's really baffling. The Hindenburg team began hearing from people all over the world.

The reaction was like, holy shit, like, what are you even talking about? Fake magician who lies about scientific research is not the norm for, you know, criticism of a public company listed on the Nasdaq. Sure enough, Enochian's share price dropped again. Hindenburg's report had spooked investors and their short sell had worked.

Yes, in this case, we did make more than the cost of research for our short. Nate won't say how much they made, but the risk had paid off. Sometimes you can even be right on facts, wrong on timing. There's all sorts of reasons why a stock can go up. So it is often a very risky, I mean, always really a risky endeavor. But yeah, no, this one was one that worked for us.

Enochian's reaction to the story was immediate. The day the story went up, its CEO Mark Dybul wrote a letter to Enochian shareholders. I have spoken to some of you about the serious and disturbing news that broke last week about Serhat Gumruchu. They try and tell us in the press release there has never been a formal role for Gumruchu in the company.

And his remaining informal role as a scientific advisor is concluded. So they kind of say, we stand by his credentials, but he's not got a hand in the day-to-day running of the company. This was damage control. So the company came out and said that they strongly refuted our findings. But noticeably, in the press release where they claimed that everything was great, they stopped referring to Sirhat as Dr. Sirhat.

They just started calling him Serhat at that point. Anokyan called Hindenburg's article, quote, "...misleading propaganda intended to drive the company's stock price down." They said there had never been a formal role for Serhat in the company and that his informal role of scientific advisor had concluded...

And they were insistent that their patents still had the potential to cure deadly diseases. In other words, they were saying that even if Serhat was a multiple fraudster and suspected murderer, his ideas still had merit. Dybul wrote: "The science is the science. The data are the data." But how could Serhat's medical miracles be believed if it lied about everything else?

One of the people focused on that question was Zeb. He was wondering what it meant for his friend Jeffrey. The very first thing I was concerned with was, "Is Jeffrey okay?"

I started to trace back in my mind all of the times where he appeared sick or run down. I started to question, like, was his undetectable status real? You know, like, why? It just, everything started to flash in my mind. And Jeffrey was very quick to reassure me and everyone that he was okay. But I don't believe that he was super okay.

Zeb knew that Jeffrey didn't want to ruin the trial by going back on his old medication. Even when he'd been too sick to leave his house, he hadn't given up on Serhat's cure. So Jeffrey called Serhat's clinic. And called. And called. No one there could tell him what to do. So he went back on a regimen of antiretroviral drugs and ended his HIV treatment trial.

We reached out to Mark Dybul from Enochian about Jeffrey's treatment and he responded, "We had no involvement in the administration of this treatment to Mr. Drew. Moreover, Enochian had no involvement with any treatment conducted by Seraph Clinic and did not work with the Seraph Research Institute on any HIV treatment."

Mark Dybel, however, was aware of Jeffrey's trial, and Anokian stood to benefit financially from any positive outcome. As far as Zeb could tell, the whole thing was a huge loss for his friend. When we would do these press events and these Q&As, the just...

pride that he felt for potentially being a part of something that would help so many people was just massive for him. And so when all of that got taken away and suddenly he got put back on medication, it was devastating. Jeffrey had spent two years of his life sacrificing his well-being in the search for a cure. Had it all been a sham?

We'll never know how much this has affected his physical body and what the ramifications of this will be. And will he be able to withstand, like, cancer or some other type of sickness or disease that comes with life? It's incredibly infuriating. We did reach out to Jeffrey for this story, but he declined to comment. Not long after Serhat's arrest, Zeb's documentary on Jeffrey was taken down by the streaming service that bought it.

For Zeb, that was tragic. I feel like in this entire tsunami of terrible bullshit, Jeffrey's story has been totally lost. And his act of service and his just willingness to put his life on the line to honor his fallen brothers that have died from this disease has totally been lost.

A month after Hindenburg's article came out, another statement was posted on Enochian's website. The company said they'd been reviewing Serhat's test results. Quote, The results of this investigation verified key primary data for the company's HIV and cancer pipelines. But that wasn't all. The company also disclosed that Serhat had faked the results of animal studies for their COVID and hepatitis B treatments,

In this case, the data wasn't the data. As a result, the company will initiate legal action against Gumrukcu over the falsified data. Enochian was now taking to court its own inventor and co-founder, the man they described as a genius.

They sued Surha alleging that they had been duped and they had no idea that it was just a big fraud all along. And how could this happen? Just such a horrific surprise. And my thought was that this was just entirely disingenuous to show if anyone asks, like, look, we were also surprised by this. We had no idea. I mean, we were in line to make tens of millions of dollars from these lies and there are red flags all over the place. But how could anyone have seen this?

By the time the lawsuit was filed, Enochian's share price had fallen to $2.11 a share, and the company and its investors had lost hundreds of millions of dollars as a result.

The largest holder of Hinokian stock was Sirhat Gamruku himself and his family members and related entities. So the biggest loser in the stock market was Sirhat himself, which is exactly how it should be in our view. The CEO and several other executives and board members had stock, so they also lost significant amounts of their paper holdings.

The fallout from the revelations about Serhat was worse for the patients and the people who loved them, those who had placed their hope in Serhat's hands. I think what he did was he prayed on vulnerability wherever he could find it and looked for the absolute most vulnerable people possible.

What was going through Serhat's mind as he offered these treatments? It's tough to pinpoint the motivation for Serhat.

Certainly money. I think he was motivated also by fame. I think possibly motivated by a desire for respect amongst peers or intelligent people. But perhaps there's something else. That same look that his old school friend saw in his eyes long ago back in Turkey. That same hysteria when he first saw a magic trick. The delight of deception.

A lot of times with someone like him, they're also motivated by a joy in tricking people and using his wits to get money from people, like a predator that feels a sense of joy from his prey.

All right, welcome back inside our proactive newsroom. And joining me now is Dr. Mark Dybul. In late 2023, Enochian's CEO was excited to make an announcement. He is the CEO of Renovaro Biosciences. And Dr. Dybul, great to see you. How are you? Great. How are you? Nice to be with you, Steve. Thanks for inviting me. Enochian had a new name and a new focus.

Renoboro, it means to renew, is focused on platform approaches to strengthen our own immune system, to renew the immune system, to retrain it so that it can control diseases on its own. With a new name came a new focus on cancer. They were planning a merger with an up-and-coming AI company to supercharge their cancer detection. And that HIV treatment that Jeffrey went through so much for

In their annual report, the company announced they were dropping plans to make it into a clinical trial. In a separate statement to us, Mark Dybul said the results from the patient were promising and that he's hopeful the approach will be evaluated. As Enochian went public with the rebrand, their stock surged once more.

Nate has seen it all before. I think it's just a cheap tactic to try and sort of gloss over the fact that they had just run this massive entity filled with lies and just change the story a little bit and see if they can sell the new story to people.

And sadly, I think it will work. I think it's already clear that they've managed to pump their stock back up. They've got people excited about this new AI venture that seems completely outrageous. And my guess is they will, if they haven't already, dump stock on the people that are buying into the new story. And I think they'll probably just keep doing it over and over and over again until and unless they are actually stopped.

Meanwhile, one of the largest shareholders of Renovaro stock is behind bars. Serhat is still awaiting trial on murder-for-hire charges relating to the kidnapping and death of Gregory Davis. He has pled not guilty. If convicted, he faces up to life in prison. Serhat's trial isn't scheduled to start until October 2024.

We reached out to him, his family, and his attorneys, but all declined to comment. In the meantime, according to Serhat's friend Brooke Casey, he's making the most of his time behind bars. He sort of sees this as an opportunity. He's been, you know, raising the consciousness of the people that he's met in incarceration. Teaching meditation, teaching yoga, he's taking this as this moment to...

meditate and to have access to people that he wouldn't have had access to. People who might be looking for a guru or a magician or a genius who can make all of their problems vanish. I think in that respect, I'm very fortunate. I can say pretty much over 90% of things I've come up with panned out.

And the less than 10% that didn't pan out taught me a lot. If you like Dr. Death, you can listen ad-free right now by joining Wondery Plus in the Wondery app or on Apple Podcasts. Prime members can listen ad-free on Amazon Music. Before you go, tell us about yourself by filling out a short survey at wondery.com slash survey.

Have you ever gotten a message out of the blue? Maybe you ignore them. Or maybe you end up in conversation. Maybe they tell you about an amazing offer. I can really show you how to make some money. And maybe that gets you into a lot of trouble. But this isn't a story about people like you. The people receiving these messages.

This is a story about the people behind the messages, on the other end of the line. Thousands of them working in a microcity built for scammers.

From Wondery, the makers of Dr. Death and Kill List, comes Scam Factory, a new series about survival at the expense of others. Follow Scam Factory on the Wondery app or wherever you get your podcasts. You can listen to Scam Factory early and ad-free right now by joining Wondery Plus in the Wondery app or on Apple Podcasts.

From Wondery, this is episode five of five of Dr. Death, Bad Magic.

I'm your host, Laura Beale. This series is written by Benjamin Gray. Producer is Nika Singh. Senior producer is Russell Finch. Story editor is Allison Weintraub. Senior editor is Rachel B. Doyle. Fact-checking by Jacqueline Colletti. Additional reporting by Gulsin Harman and Alyssa Jong Perry. Production assistance by Mariah Dennis and Emily Locke. Sound design and mixing by Kyle Randall.

Senior Managing Producer is Lata Pandya. Coordinating Producer is Heather Beloga. Produced by Storyforce. Music Supervisor is Scott Velasquez for Freesan Sync.

Special thanks to Jesper Pedersen, to Ali Dashti and Guy Rokin of the Fancy Labcoat Guild podcast, and to Nate Anderson and the staff at Hindenburg Research for use of their reporting. Executive producers are Bly Pagan-Faust and Corey Shepard-Stern for Storyforce. Our executive producers are George Lavender, Marshall Louis, and Jen Sargent for Wondery. Wondery.

We're sunsetting PodQuest on 2025-07-28. Thank you for your support!

Export Podcast Subscriptions